|

RO7795081 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CT-996, RG6652

Pipeline

Phase 2: 1

Top Sponsors

  • Hoffmann-La Roche1

Indications

  • Type 2 Diabetes Mellitus1
  • Diabetes1

Tucson, Arizona1 trial

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Arizona Liver Health - Tucson

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.